Clinical significance of molecular detection of matrix metalloproteinase-1 in bone marrow and peripheral blood in patients with gastric cancer

Annals of Surgical Oncology

Volumn 19, Issue SUPPL. 3, 2012, Pages

  Kosaka, Yoshimasa ^a,c   Mimori, Koshi ^a   Fukagawa, Takeo ^b   Ishikawa, Kenji ^a   Etoh, Tsuyoshi ^b   Katai, Hitoshi ^b   Sano, Takeshi ^b   Watanabe, Masahiko ^c   Sasako, Mitsuru ^b   Mori, Masaki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERSTITIAL COLLAGENASE; MESSENGER RNA;

ADULT; AGED; ARTICLE; BONE MARROW; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BONE MARROW; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; GENES, NEOPLASM; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; STOMACH NEOPLASMS; TUMOR BURDEN;

EID: 84865031923     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1905-y     Document Type: Article

References (42)

1. S Braun FD Vogl B Naume, et al. 2005 A pooled analysis of bone marrow micrometastasis in breast cancer N Engl J Med. 353 793 802 16120859 10.1056/NEJMoa050434 1:CAS:528:DC%2BD2MXovVKlu7s%3D
2. K Pantel U Woelfle 2004 Micrometastasis in breast cancer and other solid tumors J Biol Regul Homeost Agents. 18 120 125 15471214 1:CAS:528: DC%2BD2cXhtVWku7rL
3. H Seeliger H Spatz KW Jauch 2003 Minimal residual disease in gastric cancer Recent Results Cancer Res. 162 79 87 12790323 10.1007/978-3-642-59349-9-7
4. I Vogel H Kalthoff 2001 Disseminated tumour cells Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas Virchows Arch. 439 109 117 11561750 10.1007/s004280100476 1:CAS:528: DC%2BD3MXlvFWqsb4%3D
5. G Tsavellas H Patel TG Allen-Mersh 2001 Detection and clinical significance of occult tumour cells in colorectal cancer Br J Surg. 88 1307 1320 11578283 10.1046/j.0007-1323.2001.01863.x 1:STN:280:DC%2BD3Mrjt1Snsg%3D%3D
6. B Bockmann HJ Grill M Giesing 2001 Molecular characterization of minimal residual cancer cells in patients with solid tumors Biomol Eng. 17 95 111 11222984 10.1016/S1389-0344(00)00073-3 1:CAS:528:DC%2BD3MXitlemtL8%3D
7. S Braun K Pantel 1999 Micrometastatic bone marrow involvement: detection and prognostic significance Med Oncol. 16 154 165 10523795 10.1007/BF02906127 1:STN:280:DyaK1Mvls1ehsA%3D%3D
8. R Calaluce BW Miedema YW Yesus 1998 Micrometastasis in colorectal carcinoma: a review J Surg Oncol. 67 194 202 9530893 10.1002/(SICI)1096- 9098(199803)67:3<194::AID-JSO11>3.0.CO;2-2 1:STN:280:DyaK1c7ovFektA%3D%3D
9. H Iinuma K Okinaga H Egami, et al. 2006 Usefulness and clinical significance of quantitative real-time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer Int J Oncol. 28 297 306 16391782 1:CAS:528:DC%2BD28XhsFSgtL0%3D
10. K Mimori T Fukagawa Y Kosaka, et al. 2008 Hematogenous metastasis in gastric cancer requires isolated tumor cells and expression of vascular endothelial growth factor receptor-1 Clin Cancer Res. 14 2609 2616 18451223 10.1158/1078-0432.CCR-07-4354 1:CAS:528:DC%2BD1cXlsV2qsbk%3D
11. MM Heiss EH Simon BC Beyer, et al. 2002 Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow J Clin Oncol. 20 2005 2016 11956259 10.1200/JCO.2002.08.003 1:CAS:528:DC%2BD38XjvVKmsr0%3D
12. MM Heiss H Allgayer KU Gruetzner R Babic KW Jauch FW Schildberg 1997 Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer Ann Surg. 226 736 744 9409572 10.1097/00000658-199712000-00010 1:STN:280:DyaK1c%2Fnt1agsg%3D%3D discussion 744-735
13. MM Heiss H Allgayer KU Gruetzner, et al. 1995 Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer Nat Med. 1 1035 1039 7489359 10.1038/nm1095-1035 1:CAS:528:DyaK2MXosVGgu7o%3D
14. F Blasi 1993 Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness Bioessays. 15 105 111 8385942 10.1002/bies.950150206 1:CAS:528:DyaK3sXks12jtL4%3D
15. MJ Duffy 1992 The role of proteolytic enzymes in cancer invasion and metastasis Clin Exp Metastasis. 10 145 155 1582084 10.1007/BF00132746 1:CAS:528:DyaK38Xls1ymu7c%3D
16. LA Liotta PS Steeg WG Stetler-Stevenson 1991 Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation Cell. 64 327 336 1703045 10.1016/0092-8674(91)90642-C 1:CAS:528:DyaK3MXpvFWktA%3D%3D
17. M Egeblad Z Werb 2002 New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer. 2 161 174 11990853 10.1038/nrc745 1:CAS:528:DC%2BD38Xis1KktL8%3D
18. MD Sternlicht Z Werb 2001 How matrix metalloproteinases regulate cell behavior Annu Rev Cell Dev Biol. 17 463 516 11687497 10.1146/annurev.cellbio.17. 1.463 1:CAS:528:DC%2BD3MXos1Omsbs%3D
19. CE Brinckerhoff JL Rutter U Benbow 2000 Interstitial collagenases as markers of tumor progression Clin Cancer Res. 6 4823 4830 11156241 1:CAS:528:DC%2BD3MXotleksw%3D%3D
20. J Shiozawa M Ito T Nakayama M Nakashima S Kohno I Sekine 2000 Expression of matrix metalloproteinase-1 in human colorectal carcinoma Mod Pathol. 13 925 933 11007031 10.1038/modpathol.3880169 1:STN:280:DC%2BD3cvltFensQ%3D%3D
21. Y Kanamori M Matsushima T Minaguchi, et al. 1999 Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region Cancer Res. 59 4225 4227 10485461 1:CAS:528:DyaK1MXlvVSmsr4%3D
22. T Ito M Ito J Shiozawa S Naito T Kanematsu I Sekine 1999 Expression of the MMP-1 in human pancreatic carcinoma: relationship with prognostic factor Mod Pathol. 12 669 674 10430270 1:STN:280:DyaK1Mzlsleguw%3D%3D
23. GI Murray ME Duncan P O'Neil JA McKay WT Melvin JE Fothergill 1998 Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer J Pathol. 185 256 261 9771478 10.1002/(SICI)1096-9896(199807)185:3<256::AID- PATH115>3.0.CO;2-A 1:CAS:528:DyaK1cXlsVOiu74%3D
24. GI Murray ME Duncan P O'Neil WT Melvin JE Fothergill 1996 Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer Nat Med. 2 461 462 8597958 10.1038/nm0496-461 1:CAS:528:DyaK28XitVKmtrY%3D
25. L Nakopoulou I Giannopoulou H Gakiopoulou H Liapis A Tzonou PS Davaris 1999 Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features Hum Pathol. 30 436 442 10208466 10.1016/S0046-8177(99)90120-X 1:CAS:528:DyaK1MXivVSrurs%3D
26. T Inoue M Yashiro S Nishimura, et al. 1999 Matrix metalloproteinase-1 expression is a prognostic factor for patients with advanced gastric cancer Int J Mol Med. 4 73 77 10373641 1:STN:280:DyaK1Mzgtl2mtg%3D%3D
27. K Airola T Karonen M Vaalamo, et al. 1999 Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas Br J Cancer. 80 733 743 10360651 10.1038/sj.bjc.6690417 1:CAS:528:DyaK1MXjsV2rurY%3D
28. LH Sobin ID Fleming 1997 TNM Classification of Malignant Tumors, fifth edition (1997) Union Internationale Contre le Cancer and the American Joint Committee on Cancer Cancer. 80 1803 1804 9351551 10.1002/(SICI)1097- 0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9 1:STN:280: DyaK1c%2FhtF2itA%3D%3D
29. TA Masuda H Inoue H Sonoda, et al. 2002 Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis Cancer Res. 62 3819 3825 12097295 1:CAS:528:DC%2BD38XltF2jurY%3D
30. M Mori K Mimori H Inoue, et al. 1995 Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction Cancer Res. 55 3417 3420 7542169 1:CAS:528:DyaK2MXnt1antrs%3D
31. Sasse EA. How to define and determine reference intervals in the clinical laboratory: approved guideline. 2000.
32. H Sugai K Kono A Takahashi, et al. 2004 Characteristic alteration of monocytes with increased intracellular IL-10 and IL-12 in patients with advanced-stage gastric cancer J Surg Res. 116 277 287 15013367 10.1016/j.jss.2003.10.008 1:CAS:528:DC%2BD2cXptFSlsA%3D%3D
33. LV Beerepoot N Mehra JS Vermaat BA Zonnenberg MF Gebbink EE Voest 2004 Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients Ann Oncol. 15 139 145 14679134 10.1093/annonc/mdh017 1:STN:280:DC%2BD3srps1Kltg%3D%3D
34. P Mancuso A Burlini G Pruneri A Goldhirsch G Martinelli F Bertolini 2001 Resting and activated endothelial cells are increased in the peripheral blood of cancer patients Blood. 97 3658 3661 11369666 10.1182/blood.V97.11.3658 1:CAS:528:DC%2BD3MXktFOku7k%3D
35. YS Chang E di Tomaso DM McDonald R Jones RK Jain LL Munn 2000 Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood Proc Natl Acad Sci USA. 97 14608 14613 11121063 10.1073/pnas.97.26.14608 1:CAS:528:DC%2BD3MXitVGitw%3D%3D
36. P Beaudry J Force GN Naumov, et al. 2005 Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity Clin Cancer Res. 11 3514 3522 15867254 10.1158/1078-0432.CCR-04-2271 1:CAS:528:DC%2BD2MXjslOqtLk%3D
37. Y Lin DJ Weisdorf A Solovey RP Hebbel 2000 Origins of circulating endothelial cells and endothelial outgrowth from blood J Clin Invest. 105 71 77 10619863 10.1172/JCI8071 1:CAS:528:DC%2BD3cXislSrtg%3D%3D
38. T Asahara T Murohara A Sullivan, et al. 1997 Isolation of putative progenitor endothelial cells for angiogenesis Science. 275 964 967 9020076 10.1126/science.275.5302.964 1:CAS:528:DyaK2sXht1Clu7k%3D
39. BA Peters LA Diaz K Polyak, et al. 2005 Contribution of bone marrow-derived endothelial cells to human tumor vasculature Nat Med. 11 261 262 15723071 10.1038/nm1200 1:CAS:528:DC%2BD2MXhvVSqsr0%3D
40. S Barille M Collette W Thabard C Bleunven R Bataille M Amiot 2000 Soluble IL-6R alpha upregulated IL-6, MMP-1 and MMP-2 secretion in bone marrow stromal cells Cytokine. 12 1426 1429 10976008 10.1006/cyto.2000.0734 1:CAS:528:DC%2BD3cXmt1aitbs%3D
41. LA Liotta K Tryggvason S Garbisa I Hart CM Foltz S Shafie 1980 Metastatic potential correlates with enzymatic degradation of basement membrane collagen Nature. 284 67 68 6243750 10.1038/284067a0 1:CAS:528:DyaL3cXktVGmsbw%3D
42. Y Kosaka K Mimori T Fukagawa, et al. 2007 Identification of the high-risk group for metastasis of gastric cancer cases by vascular endothelial growth factor receptor-1 overexpression in peripheral blood Br J Cancer. 96 1723 1728 17486129 10.1038/sj.bjc.6603785 1:CAS:528:DC%2BD2sXlvVShtrw%3D